1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Oncology Therapeutics Market to 2017 - High Unmet Need in
the Management and Treatment of Metastatic Cancers to Drive
Drug Development
http://www.aarkstore.com/reports/Oncology-Therapeutics-Market-to-2017-
High-Unmet-Need-in-the-Management-and-Treatment-of-Metastatic-Cancers-
to-Drive-Drug-Development-177386.html
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Company, the leading business intelligence provider, has released its latest research,
“Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and
Treatment of Metastatic Cancers to Drive Drug Development”, which provides
insights into the global oncology therapeutics market and market forecasts until
2017. The report provides an in-depth analysis of major oncology indications, which

2. includes breast cancer, colorectal cancer, Non-Hodgkin’s lymphoma (NHL), Non-
Small Cell Lung Cancer (NSCLC), prostate cancer, ovarian cancer, cervical cancer and
head and neck cancer. The report also includes insights into the oncology
therapeutics R&D pipeline. It analyzes the competitive landscape in the oncology
therapeutics market through analysis of M&A, licensing and co-development deals.
The report is built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by Company’s team of
industry experts.
Scope
- Data and analysis on the global oncology therapeutics market in the leading
geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
- Annualized market data for the oncology therapeutics market from 2002-2010
with forecasts to 2017.
- Market data on the therapeutic landscape which covers breast cancer, colorectal
cancer, NHL, NSCLC, prostate cancer, ovarian cancer, cervical cancer and head and
neck cancer. This includes market size, market share, annual cost of therapy,
treatment flow algorithm and branded and generic share.
Table of contents:
1.1 List of Tables 7
1.2 List of Figures 11
2 Oncology Therapeutics Market to 2017 - Introduction 14
2.1 Company Report Guidance 15
3 Oncology Therapeutics Market to 2017 - Market Overview 16
3.1 Revenue Forecasts for Oncology Therapeutics Market 16
3.1.1 Revenue 16
3.1.2 Annual Cost of Treatment 22
3.2 Treatment Usage Patterns 23
3.3 Drivers and Barriers for Oncology Therapeutics Market 25
3.3.1 Drivers 25
3.3.2 Barriers 26

3. 4 Oncology Therapeutics Market to 2017 - Geographical Landscape 28
4.1 The US 28
4.1.1 Revenue 28
4.1.2 Annual Cost of Treatment 29
4.1.3 Treatment Usage Patterns 30
4.2 Top Five Countries of Europe 32
4.2.1 Revenue 32
4.2.2 Annual Cost of Treatment 33
4.2.3 Treatment Usage Patterns 34
4.3 Japan 36
4.3.1 Revenue 36
4.3.2 Annual Cost of Treatment 37
4.3.3 Treatment Usage Patterns 38
5 Oncology Therapeutics Market to 2017 - Therapeutic Landscape 40
5.1 Breast Cancer 40
5.1.1 Introduction 40
5.1.2 Survival Rates by Stage 42
5.1.3 Symptoms 42
5.1.4 Treatment Flow 43
5.1.5 Revenue 46
5.1.6 Annual Cost of Treatment 50
5.1.7 Treatment Usage Patterns 51
5.1.8 Drivers and Barriers for Breast Cancer Therapeutics Market 53
5.2 Colorectal Cancer 55
List of Figures
List of Tables are also include.
For more Discounted Reports Plz follow The link:
Spinal Surgery Devices Market - Global Pipeline Analysis, Competitive Landscape
and Market Forecasts to 2017 - Motion Preserving Spinal Non-Fusion Procedures to

4. Drive Long Term Growth
Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices,
Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic
Surgery Market
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify
Following Patent Expiries of Lyrica and Cymbalta
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/market-sector-reports/Pharmaceuticals-&-Healthcare-
7.html
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and
Vaccines Therapeutic Classes Dominate Late-Stage Pipeline
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified
Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate
Scope of Current Late Stage Molecules
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com